Business Insider11h
Cellebrite DI: Strategic Focus on Inseyets Platform and Complementary Applications Drive Buy Rating with Over 20% Upside Potential
William Blair analyst Jonathan Ho has maintained their bullish stance on CLBT stock, giving a Buy rating today. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily ...
Serbia used Israeli firm’s tech to enable spy campaign, Amnesty says
Serbian officials installed homegrown spyware on the phones of dozens of journalists and activists, Amnesty International ...
Amnesty calls out Cellebrite DI (CLBT) for spy tech misuse in Serbia
Cellebrite DI has come under pressure after an allegation that its tech was used for unethical practices in Serbia. The ...
Cellebrite price target raised to $24 from $22 at JPMorgan
JPMorgan raised the firm’s price target on Cellebrite (CLBT) to $24 from $22 and keeps an Overweight rating on the shares. The firm updating ...
Analysts Set Cellebrite DI Ltd. (NASDAQ:CLBT) PT at $20.29
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have received an average recommendation of “Buy” from the eight research firms that are currently covering the company, Marketbeat.com ...
news.stocktradersdaily3d
(CLBT) On The My Stocks Page
Check the time stamp on this data. Updated AI-Generated Signals for Cellebrite Di Ltd. (CLBT) available here: CLBT.